In detail, KRAS-mutated CRCs had a lower frequency in MSI-High (15% vs. 42%; p = 0.015) compared with KRAS-WT, though KRAS mutation was associated with higher tumor-cell turnover [13]. The gene discussed is KRAS; the disease is neoplasm.